Research & Development

Gene7 Biotech PVT Ltd (GBL) Research and Development activities focus on developing innovative probiotic solutions through fermentation technology leading to improvements in yields and robustness. We continuously improve on the quality of our products in order to meet the demands of our existing and potential clients.

New isolates identified by molecular tools which include PCR based techniques and 16S rRNA sequencing are stored in our culture collection before they are screened.


Development of new products require screening of thousands of candidates for the right bacterial strains most suitable for the particular application. Screening methods include

From selection of probiotic strains to initial production at small scale laboratory fermentors and then production at the pilot plant, the R & D is behind every stage to ensure safe and robust implementation.

Company Profile

Gene7 Biotech PVT Ltd (GBL) is a world class, dedicated and a well laid out large scale fermentation facility established in 2011 for Probiotics, Enzymes, and Nutraceuticals with state-of-the-art equipment in the Genome Valley, Hyderabad. We are totally committed to the discovery, development and commercialization of innovative solutions for improved healthcare at affordable cost.

GBL has dedicated blocks for production of Bacillus sp, Lactobacillus sp., Bifidobacteria sp., Saccharomyces boulardii and Serratiopeptidase.

Gene7 Biotech is an ISO 9000:2008 and a WHO-GMP certified company. Our Centre for Research and Development is recognized by Department of Scientific and Industrial Research (DSIR), Government of India. Gene7 Biotech is working in the development of disease specific probiotic solutions.

With an unparalleled and unique combination of technical know-how, skilled resources and quality manufacturing, GBL has gained worldwide prominence in the field of Probiotics and is well positioned to open up exciting new avenues and offer products that surpass global standards.